HFA
Harbert Fund Advisors’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,750
| Closed | -$1.08M | – | 22 |
|
|
2025
Q1 | $1.08M | Sell |
10,750
-6,750
| -39% | -$681K | 1.23% | 34 |
|
|
2024
Q4 | $1.56M | Buy |
17,500
+2,500
| +17% | +$223K | 0.81% | 25 |
|
|
2024
Q3 | $1.26M | Buy |
15,000
+8,475
| +130% | +$710K | 0.74% | 28 |
|
|
2024
Q2 | $502K | Sell |
6,525
-8,475
| -57% | -$653K | 0.36% | 67 |
|
|
2024
Q1 | $1.03M | Sell |
15,000
-17,500
| -54% | -$1.2M | 0.71% | 37 |
|
|
2023
Q4 | $1.88M | Buy |
32,500
+22,500
| +225% | +$1.3M | 1.29% | 22 |
|
|
2023
Q3 | $528K | Sell |
10,000
-22,500
| -69% | -$1.19M | 0.38% | 39 |
|
|
2023
Q2 | $1.76M | Sell |
32,500
-17,500
| -35% | -$947K | 0.99% | 35 |
|
|
2023
Q1 | $2.5M | Buy |
50,000
+21,100
| +73% | +$1.06M | 1.65% | 24 |
|
|
2022
Q4 | $1.34M | Sell |
28,900
-41,100
| -59% | -$1.9M | 1.07% | 32 |
|
|
2022
Q3 | $2.71M | Buy |
70,000
+48,250
| +222% | +$1.87M | 1.44% | 16 |
|
|
2022
Q2 | $811K | Buy |
+21,750
| New | +$811K | 0.39% | 31 |
|